N-of-One is a personalized health IT and diagnostic interpretation company that provides oncologists with clinically actionable interpretation of genetics mutations that exist in a patient’s tumor
Status: Acquired by Qiagen in 2019.
Location: United States, Massachusetts, Concord
Member count: 51-200
Total raised: $7M
Founded date: 2008
Investors 1
Date | Name | Website |
- | Excel Vent... | excelvm.co... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
21.07.2016 | Series B | $7M | - | hitconsult... |
Mentions in press and media 6
Date | Title | Description | Source |
22.07.2016 | N-of-One’s new funding will expand precision medicine clinic... | Cournoyer said the Lexington, Massachusetts company has raised $14 million to date. Some of the ange... | medcitynew... |
22.07.2016 | N-of-One Raises $7M for Precision Medicine Oncology Decision... | N-of-One, a precision medicine oncology decision support company has raised $7 million in funding fr... | hitconsult... |
21.07.2016 | N-of-One Raises $7M | LEXINGTON, MA, N-of-One, a precision medicine oncology decision support company, announced today t... | vcnewsdail... |
21.07.2016 | N-of-One Raises $7 Million Series B | N-of-One, a precision medicine oncology decision support company, announced today that it has receiv... | citybizlis... |
21.07.2016 | N-of-One Secures $7M in Series B Financing | N-of-One, a Lexington, Mass.-based precision medicine oncology decision support company, received $7... | finsmes.co... |
- | N-of-One’s new funding will expand precision medicine clinic... | Christine Cournoyer, N-of-One CEO More than three years after the launch of its molecular diagnosti... | medcitynew... |